Interaction between the Product of the Breast Cancer Susceptibility Gene BRCA2 and DSS1, a Protein Functionally Conserved from Yeast to Mammals

REFERENCES

• Achille, A., M. O. Biasi, G. Zamboni, G. Bogina, A. R. Magalini, P. Pederzoli, M. Perucho, and J. Scarpa 1996. Chromosome 7q allelic losses in pancreatic carcinoma. Cancer Res 56:3808–3813.
   PubMed Web of Science ®Google Scholar
• Basi, G., E. Schmid, and J. Maundrell 1993. TATA box mutations in the Schizosaccharomyces pombe nmt1 promoter affect transcription efficiency but not the transcription start point or thiamine repressibility. Gene 123:131–136.
   PubMed Web of Science ®Google Scholar
• Bertwistle, D., and J. Ashworth 1998. Functions of the BRCA1 and BRCA2 genes. Curr. Opin. Genet. Dev. 8:14–20.
   PubMed Web of Science ®Google Scholar
• Bertwistle, D., S. Swift, N. J. Marston, L. E. Jackson, S. Crossland, M. R. Crompton, C. J. Marshall, and J. Ashworth 1997. Nuclear location and cell cycle regulation of the BRCA2 protein. Cancer Res 57:5485–5488.
   PubMedGoogle Scholar
• Bignell, G., G. Micklem, M. R. Stratton, A. Ashworth, and J. Wooster 1997. The BRC repeats are conserved in mammalian BRCA2 proteins. Hum. Mol. Genet. 6:53–58.
   PubMedGoogle Scholar
• Bork, P., N. Blomberg, and J. Nilges 1996. Internal repeats in the BRCA2 protein sequence. Nat. Genet. 13:22–23.
   PubMed Web of Science ®Google Scholar
• Brewster, J. L., T. de Valoir, N. D. Dwyer, E. Winter, and J. Gustin 1993. An osmosensing signal transduction pathway in yeast. Science 259:1760–1763.
   PubMed Web of Science ®Google Scholar
• Chen, J., D. P. Silver, D. Walpita, S. B. Cantor, A. F. Gazdar, G. Tomlinson, F. J. Couch, B. L. Weber, T. Ashley, D. M. Livingston, and J. Scully 1998. Stable interaction between the products of the BRCA1 and BRCA2 tumor suppressor genes in mitotic and meiotic cells. Mol. Cell 2:317–328.
   PubMed Web of Science ®Google Scholar
• Collins, N., R. McManus, R. Wooster, J. Mangion, S. Seal, S. R. Lakhani, W. Ormiston, P. A. Daly, D. Ford, D. F. Easton et al.. 1995. Consistent loss of the wild type allele in breast cancers from a family linked to the BRCA2 gene on chromosome 13q12-13. Oncogene 10:1673–1675.
   PubMed Web of Science ®Google Scholar
• Connor, F., D. Bertwistle, P. J. Mee, G. M. Ross, S. Swift, E. Grigorieva, V. L. Tybulewicz, and J. Ashworth 1997. Tumorigenesis and a DNA repair defect in mice with a truncating Brca2 mutation. Nat. Genet. 17:423–430.
   PubMed Web of Science ®Google Scholar
• Connor, F., A. Smith, R. Wooster, M. Stratton, A. Dixon, E. Campbell, T. M. Tait, T. Freeman, and J. Ashworth 1997. Cloning, chromosomal mapping and expression pattern of the mouse Brca2 gene. Hum. Mol. Genet. 6:291–300.
   PubMedGoogle Scholar
• Couch, F. J., L. M. Farid, M. L. DeShano, S. V. Tavtigian, K. Calzone, L. Campeau, Y. Peng, B. Bogden, Q. Chen, S. Neuhausen, D. Shattuck-Eidens, A. K. Godwin, M. Daly, D. M. Radford, S. Sedlacek, J. Rommens, J. Simard, J. Garber, S. Merajver, and J. Weber 1996. BRCA2 germline mutations in male breast cancer cases and breast cancer families. Nat. Genet. 13:123–125.
   PubMed Web of Science ®Google Scholar
• Crackower, M. A., S. W. Scherer, J. M. Rommens, C. C. Hui, P. Poorkaj, S. Soder, J. M. Cobben, L. Hudgins, J. P. Evans, and J. Tsui 1996. Characterization of the split hand/split foot malformation locus SHFM1 at 7q21.3-q22.1 and analysis of a candidate gene for its expression during limb development. Hum. Mol. Genet. 5:571–579.
   PubMed Web of Science ®Google Scholar
• Evan, G. I., G. K. Lewis, G. Ramsay, and J. Bishop 1985. Isolation of monoclonal antibodies specific for human c-myc proto-oncogene product. Mol. Cell. Biol. 5:3610–3616.
   PubMed Web of Science ®Google Scholar
• Forsburg, S. 11 February 1999, revision date. Yeast flow cytometry protocol. [Online.] http://pingu.salk.edu/fcm/protocols/ycc.html [11 February 1999, last date accessed.]
   Google Scholar
• Friedman, L. S., F. C. Thistlethwaite, K. J. Patel, V. P. Yu, H. Lee, A. R. Venkitaraman, K. J. Abel, M. B. Carlton, S. M. Hunter, W. H. Colledge, M. J. Evans, and J. Ponder 1998. Thymic lymphomas in mice with a truncating mutation in Brca2. Cancer Res. 58:1338–1343.
   PubMed Web of Science ®Google Scholar
• Gayther, S. A., J. Mangion, P. Russell, S. Seal, R. Barfoot, B. A. Ponder, M. R. Stratton, and J. Easton 1997. Variation of risks of breast and ovarian cancer associated with different germline mutations of the BRCA2 gene. Nat. Genet. 15:103–105.
   PubMed Web of Science ®Google Scholar
• Gould, K. L., S. Moreno, D. J. Owen, S. Sazer, and J. Nurse 1991. Phosphorylation at Thr167 is required for Schizosaccharomyces pombe p34cdc2 function. EMBO J. 10:3297–3309.
   PubMed Web of Science ®Google Scholar
• Gretarsdottir, S., S. Thorlacius, R. Valgardsdottir, S. Gudlaugsdottir, S. Sigurdsson, M. Steinarsdottir, J. G. Jonasson, K. Anamthawat-Jonsson, and J. Eyfjord 1998. BRCA2 and p53 mutations in primary breast cancer in relation to genetic instability. Cancer Res. 58:859–862.
   PubMed Web of Science ®Google Scholar
• Gudmundsson, J., G. Johannesdottir, J. T. Bergthorsson, A. Arason, S. Ingvarsson, V. Egilsson, and J. Barkardottir 1995. Different tumor types from BRCA2 carriers show wild-type chromosome deletions on 13q12-q13. Cancer Res. 55:4830–4832.
   PubMedGoogle Scholar
• Harper, J. W., G. R. Adami, N. Wei, K. Keyomarsi, and J. Elledge 1993. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75:805–816.
   PubMed Web of Science ®Google Scholar
• Ignatius, J., S. Knuutila, S. W. Scherer, B. Trask, and J. Kere 1996. Split hand/split foot malformation, deafness, and mental retardation with a complex cytogenetic rearrangement involving 7q21.3. J. Med. Genet. 33:507–510.
   PubMedGoogle Scholar
• Ingvarsson, S., E. K. Geirsdottir, G. Johannesdottir, B. I. Sigbjornsdottir, G. Eiriksdottir, G. Ragnarsson, B. A. Agnarsson, J. Gudmundsson, J. G. Jonasson, A. Sigurdsson, V. Egilsson, and J. Barkardottir 1998. High incidence of loss of heterozygosity in breast tumors from carriers of the BRCA2 999del5 mutation. Cancer Res. 58:4421–4425.
   PubMedGoogle Scholar
• Jantti, J., J. Lahdenranta, V. M. Olkkonen, H. Soderlund, and J. Keranen 1999. SEM1, a homologue of the split hand/split food malformation candidate gene Dss1, regulates exocytosis and pseudohyphal differentiation in yeast. Proc. Natl. Acad. Sci. USA 96:909–914.
   PubMed Web of Science ®Google Scholar
• Kristjansson, A. K., G. Eiriksdottir, G. Ragnarsson, A. Sigurdsson, J. Gudmundsson, R. B. Barkardottir, J. G. Jonasson, V. Egilsson, and J. Ingvarsson 1997. Loss of heterozygosity at chromosome 7q in human breast cancer: association with clinical variables. Anticancer Res. 17:93–98.
   PubMedGoogle Scholar
• Ludwig, T., D. L. Chapman, V. E. Papaioannou, and J. Efstratiadis 1997. Targeted mutations of breast cancer susceptibility gene homologs in mice: lethal phenotypes of Brca1, Brca2, Brca1/Brca2, Brca1/p53, and Brca2/p53 nullizygous embryos. Genes Dev. 11:1226–1241.
   PubMed Web of Science ®Google Scholar
• Marais, R., Y. Light, H. F. Paterson, and J. Marshall 1995. Ras recruits Raf-1 to the plasma membrane for activation by tyrosine phosphorylation. EMBO J. 14:3136–3145.
   PubMed Web of Science ®Google Scholar
• Marston, N. Unpublished data.
   Google Scholar
• Mazoyer, S., A. M. Dunning, O. Serova, J. Dearden, N. Puget, C. S. Healey, S. A. Gayther, J. Mangion, M. R. Stratton, H. T. Lynch, D. E. Goldgar, B. A. Ponder, and J. Lenoir 1996. A polymorphic stop codon in BRCA2. Nat. Genet. 14:253–254.
   PubMedGoogle Scholar
• Miki, Y., T. Katagiri, F. Kasumi, T. Yoshimoto, and J. Nakamura 1996. Mutation analysis in the BRCA2 gene in primary breast cancers. Nat. Genet. 13:245–247.
   PubMedGoogle Scholar
• Milner, J., B. Ponder, L. Hughes-Davies, M. Seltmann, and J. Kouzarides 1997. Transcriptional activation functions in BRCA2. Nature 386:772–773.
   PubMed Web of Science ®Google Scholar
• Mizuta, R., J. M. LaSalle, H. L. Cheng, A. Shinohara, H. Ogawa, N. Copeland, N. A. Jenkins, M. Lalande, and J. Alt 1997. RAB22 and RAB163/mouse BRCA2: proteins that specifically interact with the RAD51 protein. Proc. Natl. Acad. Sci. USA 94:6927–6932.
   PubMedGoogle Scholar
• Moreno, S., A. Klar, and J. Nurse 1991. Molecular genetic analysis of fission yeast Schizosaccharomyces pombe. Methods Enzymol. 194:795–823.
   PubMed Web of Science ®Google Scholar
• Morimatsu, M., G. Donoho, and J. Hasty 1998. Cells deleted for Brca2 COOH terminus exhibit hypersensitivity to gamma-radiation and premature senescence. Cancer Res. 58:3441–3447.
   PubMedGoogle Scholar
• Neuhausen, S., T. Gilewski, L. Norton, T. Tran, P. McGuire, J. Swensen, H. Hampel, P. Borgen, K. Brown, M. Skolnick, D. Shattuck-Eidens, S. Jhanwar, D. Goldgar, and J. Offit 1996. Recurrent BRCA2 6174delT mutations in Ashkenazi Jewish women affected by breast cancer. Nat. Genet. 13:126–128.
   PubMed Web of Science ®Google Scholar
• Patel, K. J., V. P. Vu, H. Lee, A. Corcoran, F. C. Thistlethwaite, M. J. Evans, W. H. Colledge, L. S. Friedman, B. A. Ponder, and J. Venkitaraman 1998. Involvement of Brca2 in DNA repair. Mol. Cell 1:347–357.
   PubMed Web of Science ®Google Scholar
• Phelan, C. M., J. M. Lancaster, P. Tonin, C. Gumbs, C. Cochran, R. Carter, P. Ghadirian, C. Perret, R. Moslehi, F. Dion, M. C. Faucher, K. Dole, S. Karimi, W. Foulkes, H. Lounis, E. Warner, P. Goss, D. Anderson, C. Larsson, S. A. Narod, and J. Futreal 1996. Mutation analysis of the BRCA2 gene in 49 site-specific breast cancer families. Nat. Genet. 13:120–122.
   PubMed Web of Science ®Google Scholar
• Rajan, J. V., S. T. Marquis, H. P. Gardner, and J. Chodosh 1997. Developmental expression of Brca2 colocalizes with Brca1 and is associated with proliferation and differentiation in multiple tissues. Dev. Biol. 184:385–401.
   PubMed Web of Science ®Google Scholar
• Rothstein, R. J. 1983. One-step gene disruption in yeast. Methods Enzymol. 101:202–211.
   PubMed Web of Science ®Google Scholar
• Schaap, D., J. van der Wal, L. R. Howe, C. J. Marshall, and J. van Blitterswijk 1993. A dominant-negative mutant of raf blocks mitogen-activated protein kinase activation by growth factors and oncogenic p21ras. J. Biol. Chem. 268:20232–20236.
   PubMedGoogle Scholar
• Scherer, S. W., P. Poorkaj, T. Allen, J. Kim, D. Geshuri, M. Nunes, S. Soder, K. Stephens, R. A. Pagon, M. A. Patton et al.. 1994. Fine mapping of the autosomal dominant split hand/split foot locus on chromosome 7, band q21.3-q22.1. Am. J. Hum. Genet. 55:12–20.
   PubMedGoogle Scholar
• Scully, R., J. Chen, A. Plug, Y. Xiao, D. Weaver, J. Feunteun, T. Ashley, and J. Livingston 1997. Association of BRCA1 with Rad51 in mitotic and meiotic cells. Cell 88:265–275.
   PubMed Web of Science ®Google Scholar
• Sharan, S. K., M. Morimatsu, U. Albrecht, D. S. Lim, E. Regel, C. Dinh, A. Sands, G. Eichele, P. Hasty, and J. Bradley 1997. Embryonic lethality and radiation hypersensitivity mediated by Rad51 in mice lacking Brca2. Nature 386:804–810.
   PubMed Web of Science ®Google Scholar
• Shinohara, A., H. Ogawa, and J. Ogawa 1992. Rad51 protein involved in repair and recombination in S. cerevisiae is a RecA-like protein. Cell 69:457–470.
   PubMed Web of Science ®Google Scholar
• Siddique, H., J. P. Zou, V. N. Rao, and J. Reddy 1998. The BRCA2 is a histone acetyltransferase. Oncogene 16:2283–2285.
   PubMed Web of Science ®Google Scholar
• Sigurdsson, S., S. Thorlacius, J. Tomasson, L. Tryggvadottir, K. Benediktsdottir, J. E. Eyfjord, and J. Jonsson 1997. BRCA2 mutation in Icelandic prostate cancer patients. J. Mol. Med. 75:758–761.
   PubMed Web of Science ®Google Scholar
• Simeone, A., D. Acampora, M. Pannese, M. D’Esposito, A. Stornaiuolo, M. Gulisano, A. Mallamaci, K. Kastury, T. Druck, K. Huebner et al.. 1994. Cloning and characterization of two members of the vertebrate Dlx gene family. Proc. Natl. Acad. Sci. USA 91:2250–2254.
   PubMed Web of Science ®Google Scholar
• Suzuki, A., J. L. de la Pompa, R. Hakem, A. Elia, R. Yoshida, R. Mo, H. Nishina, T. Chuang, A. Wakeham, A. Itie, W. Koo, P. Billia, A. Ho, M. Fukumoto, C. C. Hui, and J. Mak 1997. Brca2 is required for embryonic cellular proliferation in the mouse. Genes Dev. 11:1242–1252.
   PubMed Web of Science ®Google Scholar
• Tavtigian, S. V., J. Simard, J. Rommens, F. Couch, D. Shattuck-Eidens, S. Neuhausen, S. Merajver, S. Thorlacius, K. Offit, D. Stoppa-Lyonnet, C. Belanger, R. Bell, S. Berry, R. Bogden, Q. Chen, T. Davis, M. Dumont, C. Frye, T. Hattier, S. Jammulapati, T. Janecki, P. Jiang, R. Kehrer, J. F. Leblanc, D. E. Goldgar et al.. 1996. The complete BRCA2 gene and mutations in chromosome 13q-linked kindreds. Nat. Genet. 12:333–337.
   PubMed Web of Science ®Google Scholar
• Teng, D. H., R. Bogden, J. Mitchell, M. Baumgard, R. Bell, S. Berry, T. Davis, P. C. Ha, R. Kehrer, S. Jammulapati, Q. Chen, K. Offit, M. H. Skolnick, S. V. Tavtigian, S. Jhanwar, B. Swedlund, A. K. Wong, and J. Kamb 1996. Low incidence of BRCA2 mutations in breast carcinoma and other cancers. Nat. Genet. 13:241–244.
   PubMed Web of Science ®Google Scholar
• Thorlacius, S., G. Olafsdottir, L. Tryggvadottir, S. Neuhausen, J. G. Jonasson, S. V. Tavtigian, H. Tulinius, H. M. Ogmundsdottir, and J. Eyfjord 1996. A single BRCA2 mutation in male and female breast cancer families from Iceland with varied cancer phenotypes. Nat. Genet. 13:117–119.
   PubMed Web of Science ®Google Scholar
• Vaisman, N., A. Tsouladze, K. Robzyk, S. Ben-Yehuda, M. Kupiec, and J. Kassir 1995. The role of Saccharomyces cerevisiae Cdc40p in DNA replication and mitotic spindle formation and/or maintenance. Mol. Gen. Genet. 247:123–136.
   PubMedGoogle Scholar
• Wong, A. K. C., R. Pero, P. A. Ormonde, S. V. Tavtigian, and J. Bartel 1997. RAD51 interacts with the evolutionarily conserved BRC motifs in the human breast cancer susceptibility gene brca2. J. Biol. Chem. 272:31941–31948.
   PubMed Web of Science ®Google Scholar
• Wooster, R., G. Bignell, J. Lancaster, S. Swift, S. Seal, J. Mangion, N. Collins, S. Gregory, C. Gumbs, G. Micklem et al.. 1995. Identification of the breast cancer susceptibility gene BRCA2. Nature 378:789–792.
   PubMed Web of Science ®Google Scholar